All 27 scientists at the CDC's viral hepatitis lab were told their duties were "unnecessary." Ongoing outbreak investigations ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...

Let's dive into the world of hepatitis A, B, C, D, and E – five viruses that can affect your liver, each with its own unique ...

Florida health officials say three hepatitis C cases may have been caused by unsterilized instruments and/or equipment during ...

Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

Despite knowing how to prevent vertical transmission (from mother to the baby) of HIV, syphilis and hepatitis-B infections, ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

Precision BioSciences (DTIL) announced that the FDA has granted fast track designation for PBGENE-HBV, the company’s lead wholly owned in vivo ...

The highly contagious, vaccine-preventable disease inflames the liver and has seen rising outbreaks among men who have sex ...